The conversation about chemsex and sexual health has intensified across Europe as professionals and communities seek practical, nonjudgmental responses. This article summarizes recent developments: a new clinic approach in Geneva, a regional conference in Poitiers scheduled for 21 April 2026, and a call for participation in a short survey published on 16 March 2026. These initiatives aim to reduce risks such as overdose, sexually transmitted infections and dependence while improving access to prevention like PrEP and testing.
People directly involved—health workers, community organisations and men who have sex with men—are emphasizing responses that combine medical care, harm reduction and social support. The goal is to reach individuals through multiple entry points: hospital services, community centres and targeted public health actions. Together, these responses foreground practical tools and respectful care to make it easier to seek help and to prevent harms linked to the practice of using psychoactive substances during sexual encounters.
Why the link between chemsex and sexual health matters
At its core, the issue connects behavioural, biomedical and social factors. Chemsex often involves substances chosen for their capacity to increase arousal or endurance, and the behaviour can raise the likelihood of unprotected sex, prolonged sessions and reduced capacity to consent. That combination elevates risks of STIs, mental health strain and dependence. Addressing these problems therefore requires a mix of prevention tools—regular testing, access to PrEP and condoms—and holistic support that recognises stigma and discrimination as barriers to care.
Defining the practice
Chemsex refers to using drugs in sexual contexts to intensify or prolong experiences. While substance use in sexual situations is not new, the specific substances, social dynamics and technologies used for chemsex create unique patterns of risk and need. Harm reduction, peer-based support and informed clinical care are central because many people who engage in chemsex describe both positive experiences and serious negative consequences.
Services and local responses: Geneva’s consultation and community care
In Geneva, the Hôpitaux Universitaires de Genève (HUG) have opened a dedicated consultation to respond to chemsex-related needs. The model starts with a first appointment to assess consumption patterns, risks and personal goals, then connects people with specialised services as needed. Crucially, this service is described as personalised and nonjudgmental and is reimbursed under LAMAL, Switzerland’s mandatory health insurance, increasing accessibility for many residents.
Complementary community initiatives
Community centres play a vital role alongside hospital services. For example, Checkpoint Genève provides outreach and follow-up for people affected by chemsex, offering long-term accompaniment and harm reduction tools. Personal stories underline the complexity: one user reported that stopping took several months and that the immediate aftermath affected work and social life. These accounts illustrate why multiple points of access—clinical and community—are essential to help people who want to change their practices.
Training, events and national strategy: the Poitiers gathering and broader priorities
The Fédération Addiction Nouvelle-Aquitaine and the regional sexual health coordination (CoReSS NA) will host a regional day on 21 April 2026 in Poitiers to share key knowledge and practical tools for professionals. Announced in a briefing authored on 13 March 2026, the event aims to equip addiction specialists, community workers and clinicians with concrete methods for identifying chemsex-related vulnerabilities, modelling care pathways and addressing consent, stigma and mental health. Participation is free but requires registration, and the agenda emphasises collaborative, locally adapted responses.
At the national level, health authorities and advocacy organisations have been advancing a comprehensive sexual health strategy that includes specific attention to chemsex. Recommendations published in recent years stress multidisciplinary, person-centred care and increased training for professionals. These combined actions—from hospital consultations to regional training days—reflect a shift toward coordinated systems that meet people where they are and reduce obstacles to help.
Finally, researchers and advocates are asking for participation: a short survey published on 16 March 2026 invites men who have sex with men to spend about 20 minutes sharing experiences to improve services and public health responses. Taking part helps shape interventions that prioritise safety, dignity and access to prevention tools such as PrEP, condoms and regular testing. If you or someone you know is affected, multiple pathways are now open to find support, from hospital consultations to community centres and regional training initiatives.